Braidwell LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Braidwell LP disclosed 81 US equity positions worth $3.5bn in its Q3 2024 13F filing. The largest position was GH at 6.1% of the reported book, followed by BBIO and NVCR.
What did Braidwell LP own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | GH GUARDANT HEALTH INC | 6.1% | $216.0m | 268,252,000 | – | ||
| 2 | BBIO BRIDGEBIO PHARMA INC | 4.1% | $145.6m | 140,838,000 | – | ||
| 3 | NVCR NOVOCURE LTD | 3.8% | $133.3m | 140,834,000 | – | ||
| 4 | CGON CG ONCOLOGY INC | Healthcare | 3.4% | $119.6m | 3,170,875 | – | |
| 5 | NUVASIVE INC | 3.2% | $111.9m | 114,206,000 | – | ||
| 6 | XENE XENON PHARMACEUTICALS INC | Healthcare | 3.0% | $106.6m | 2,707,255 | – | |
| 7 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 3.0% | $105.7m | 917,674 | – | |
| 8 | NEOGENOMICS INC | 2.7% | $96.9m | 116,381,000 | – | ||
| 9 | APGE APOGEE THERAPEUTICS INC | Healthcare | 2.7% | $96.5m | 1,643,226 | – | |
| 10 | APLSUSD APELLIS PHARMACEUTICALS INC | 2.6% | $90.1m | 3,125,183 | – | ||
| 11 | IRONWOOD PHARMACEUTICALS INC | 2.3% | $82.5m | 92,740,000 | – | ||
| 12 | DEXCOM INC | 2.3% | $82.3m | 92,700,000 | – | ||
| 13 | ALGN ALIGN TECHNOLOGY INC | Healthcare | 2.2% | $79.3m | 311,679 | – | |
| 14 | GH GUARDANT HEALTH INC | Healthcare | 2.2% | $76.7m | 3,342,124 | – | |
| 15 | PODD INSULET CORP | 2.2% | $76.4m | 63,800,000 | – | ||
| 16 | LEGN LEGEND BIOTECH CORP | Healthcare | 2.1% | $75.1m | 1,541,551 | – | |
| 17 | VKTX VIKING THERAPEUTICS INC | Healthcare | 2.1% | $73.2m | 1,156,977 | – | |
| 18 | KINIKSA PHARMACEUTICALS INTL | 2.1% | $72.3m | 2,894,513 | – | ||
| 19 | PEN PENUMBRA INC | Healthcare | 2.0% | $70.2m | 361,428 | – | |
| 20 | DEXCOM INC | 2.0% | $70.1m | 73,500,000 | – | ||
| 21 | MRVI MARAVAI LIFESCIENCES HLDGS I | Healthcare | 2.0% | $69.4m | 8,353,287 | – | |
| 22 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 1.9% | $67.9m | 4,873,853 | – | ||
| 23 | SYRE SPYRE THERAPEUTICS INC | 1.8% | $64.4m | 2,189,836 | – | ||
| 24 | RGEN REPLIGEN CORP | Healthcare | 1.7% | $59.0m | 396,781 | – | |
| 25 | IRTC IRHYTHM TECHNOLOGIES INC | Healthcare | 1.6% | $58.1m | 782,557 | – | |
| 26 | TRAVERE THERAPEUTICS INC | 1.5% | $53.5m | 56,031,000 | – | ||
| 27 | ALPHATEC HLDGS INC | 1.5% | $52.5m | 58,217,000 | – | ||
| 28 | ARGX ARGENX SE | Healthcare | 1.5% | $52.4m | 96,724 | – | |
| 29 | EWTX EDGEWISE THERAPEUTICS INC | 1.5% | $52.3m | 1,958,310 | – | ||
| 30 | INSP INSPIRE MED SYS INC | Healthcare | 1.4% | $50.4m | 238,911 | – | |
| 31 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 1.3% | $46.3m | 370,400 | – | |
| 32 | BBIO BRIDGEBIO PHARMA INC | 1.3% | $45.0m | 53,594,000 | – | ||
| 33 | ISRG INTUITIVE SURGICAL INC | Healthcare | 1.3% | $44.9m | 91,300 | – | |
| 34 | AVADEL PHARMACEUTICALS PLC | 1.3% | $44.4m | 3,388,939 | – | ||
| 35 | BCAX BICARA THERAPEUTICS INC | 1.2% | $42.2m | 1,657,600 | – | ||
| 36 | KROS KEROS THERAPEUTICS INC | Healthcare | 1.2% | $41.1m | 707,240 | – | |
| 37 | GKOS GLAUKOS CORP | Healthcare | 1.2% | $40.6m | 311,616 | – | |
| 38 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 1.1% | $39.0m | 183,818 | – | |
| 39 | PCVX VAXCYTE INC | Healthcare | 1.0% | $34.0m | 297,568 | – | |
| 40 | REPL REPLIMUNE GROUP INC | Healthcare | 1.0% | $33.7m | 3,070,837 | – | |
| 41 | ARVN ARVINAS INC | Healthcare | 0.9% | $31.6m | 1,284,472 | – | |
| 42 | KRYS KRYSTAL BIOTECH INC | Healthcare | 0.9% | $30.7m | 168,691 | – | |
| 43 | KIDS ORTHOPEDIATRICS CORP | Healthcare | 0.9% | $30.0m | 1,107,770 | – | |
| 44 | DXCM DEXCOM INC | Healthcare | 0.8% | $29.6m | 441,086 | – | |
| 45 | BNTX BIONTECH SE | Healthcare | 0.8% | $29.4m | 247,750 | – | |
| 46 | FNAUSD PARAGON 28 INC | 0.8% | $27.6m | 4,135,109 | – | ||
| 47 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.7% | $24.8m | 3,499,427 | – | |
| 48 | ATEC ALPHATEC HLDGS INC | Healthcare | 0.6% | $22.5m | 4,041,065 | – | |
| 49 | HROW HARROW INC | 0.6% | $19.8m | 439,638 | – | ||
| 50 | CGEM CULLINAN THERAPEUTICS INC | Healthcare | 0.6% | $19.7m | 1,176,173 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.